Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Gallbladder toxicity, including cholecystitis, has been reported with motesanib, an orally administered small-molecule antagonist of VEGFRs 1, 2 and 3; PDGFR; and Kit. We assessed effects of motesanib on gallbladder size and function. |